Qin Xie
Director/Board Member at CUTIA THERAPEUTICS
Profile
Qin Xie is currently a Director at Cutia Therapeutics (Shanghai) Co., Ltd.
and a Non-Executive Director at Cutia Therapeutics.
Previously, Dr. Xie held positions as a Managing Director at Frontline Bioventures, a Senior Investment Manager at Shanghai Pharmaceuticals Holding Co., Ltd., a Manager-Business Development at Hisun Pfizer Pharmaceuticals Co., Ltd., and a Member-Supervisory Board at Ocumension Therapeutics.
Dr. Xie completed a graduate degree at the University of Oxford in 2004, a doctorate degree at the University of Oxford in 2011, and an undergraduate degree at Xi'an Jiaotong University in 2003.
Qin Xie active positions
| Companies | Position | Start |
|---|---|---|
| CUTIA THERAPEUTICS | Director/Board Member | 2019-08-22 |
Cutia Therapeutics (Shanghai) Co., Ltd.
 Cutia Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Cutia Therapeutics, Cutia Therapeutics (Shanghai) Co., Ltd. develops therapeutics to treat severe facial acne vulgaris. The private company is based in Shanghai, China. The Chinese company was founded in 2019. The CEO is Le Le Zhang. | Director/Board Member | - |
Former positions of Qin Xie
| Companies | Position | End |
|---|---|---|
Hisun Pfizer Pharmaceuticals Co., Ltd.
 Hisun Pfizer Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Hisun Pfizer Pharmaceuticals Co., Ltd. engages in the development, production, marketing, and sale of pharmaceutical products. It offers medicine in the form of tablets, hard capsules, and injection. The company was founded on September 6, 2012 and is headquartered in Hangzhou, China. | Corporate Officer/Principal | 2015-11-30 |
| SHANGHAI PHARMACEUTICALS HOLDING CO., LTD | Chief Investment Officer | 2012-11-30 |
| Frontline Bioventures | Chief Executive Officer | - |
| OCUMENSION THERAPEUTICS | Director/Board Member | - |
Training of Qin Xie
| University of Oxford | Doctorate Degree |
| Xi'an Jiaotong University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| SHANGHAI PHARMACEUTICALS HOLDING CO., LTD | Health Technology |
| OCUMENSION THERAPEUTICS | Health Technology |
| CUTIA THERAPEUTICS | Health Technology |
| Private companies | 3 |
|---|---|
| Frontline Bioventures | Finance |
Hisun Pfizer Pharmaceuticals Co., Ltd.
Hisun Pfizer Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Hisun Pfizer Pharmaceuticals Co., Ltd. engages in the development, production, marketing, and sale of pharmaceutical products. It offers medicine in the form of tablets, hard capsules, and injection. The company was founded on September 6, 2012 and is headquartered in Hangzhou, China. | Health Technology |
Cutia Therapeutics (Shanghai) Co., Ltd.
Cutia Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Cutia Therapeutics, Cutia Therapeutics (Shanghai) Co., Ltd. develops therapeutics to treat severe facial acne vulgaris. The private company is based in Shanghai, China. The Chinese company was founded in 2019. The CEO is Le Le Zhang. | Health Technology |
- Stock Market
- Insiders
- Qin Xie
